Code of Ethics
At Foused Pharma, compliance is regarded as far more than merely ticking regulatory boxes. It represents the company’s clear stance and vision that compliance is the cornerstone of every business activity. Each employee is expected to embrace this mindset and let it guide their daily decisions. To embed this approach throughout the organization, Focused Pharma has adopted the Group Code of Conduct, a single, shared set of ethical and compliance standards that secures consistent, worldwide adherence in all business operations.
Vision
At Focused Pharma, we tirelessly push the frontiers of science and study the ever-shifting healthcare landscape from every angle to uncover unmet clinical challenges. Our pledge is to create greater value for patients and health systems across the globe. We fulfill this promise by harnessing our unique capabilities to develop breakthrough therapies and craft solutions that broaden access to care and elevate health outcomes.
Focused Pharma is a Malta-based specialty pharmaceutical company dedicated to advancing urological health. Leveraging the island’s vibrant life-sciences ecosystem and EU-level regulatory framework, we research, develop, and commercialise innovative therapies that address bladder dysfunction, prostate disorders, and related pelvic-health conditions.
Our multidisciplinary team unites clinical insight with cutting-edge drug-delivery technologies, enabling us to transform scientific discoveries into practical solutions that improve patient quality of life. From early-stage research through GMP manufacturing and post-market surveillance, every step reflects our commitment to rigorous compliance, ethical integrity, and patient-centric design.
Through strategic partnerships with leading academic centres, hospitals, and technology providers, Focused Pharma is building a robust pipeline of novel treatments and combination devices aimed at unmet needs in urology. Anchored in Malta yet connected to global networks, we strive to broaden access to effective care and set new standards in urological therapeutics.